Two weeks after Dr. Hahn sent his first signal to the public that OTC sales of CBD have a bright future in America, he admits for the first time that the FDA is working with the White House to provide long-awaited clarity on CBD within “the next few months”:
“It’s taken us a bit of time within the agency to get to this point. I’m pretty comfortable that we’re going to work forward in the next few months to actually get this. We’re working through the process within the department and The White House to get to that point.”